{
    "PubTator3": [
        {
            "_id": "32202242|None",
            "id": "32202242",
            "infons": {},
            "passages": [
                {
                    "infons": {
                        "journal": "Hematol Oncol Stem Cell Ther. 2020 Jun;13(2):61-65. doi: ",
                        "year": "2020",
                        "type": "title",
                        "authors": "Oostenbrink LVE, Jol-van der Zijde CM, Jansen-Hoogendijk AM, Pool ES, van Halteren AGS, Moes DJAR, Bredius RGM, Mohseny AB, Smiers FJW, van Tol MJD, Schilham MW, Lankester AC"
                    },
                    "offset": 0,
                    "text": "Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?",
                    "sentences": [],
                    "annotations": [
                        {
                            "id": "1",
                            "infons": {
                                "identifier": "MESH:D000755",
                                "type": "Disease",
                                "valid": true,
                                "normalized": [
                                    "D000755"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D000755",
                                "biotype": "disease",
                                "name": "Anemia Sickle Cell",
                                "accession": "@DISEASE_Anemia_Sickle_Cell"
                            },
                            "text": "sickle cell disease",
                            "locations": [
                                {
                                    "offset": 89,
                                    "length": 19
                                }
                            ]
                        }
                    ],
                    "relations": []
                },
                {
                    "infons": {
                        "type": "abstract"
                    },
                    "offset": 268,
                    "text": "Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG has been introduced to optimize ATG dosing, substantial variance in clearance of active ATG, the actual lymphocyte binding component, remains a challenge. Therefore, further research regarding ATG pharmacokinetics and pharmacodynamics in different HSCT settings and in patients with different types of underlying diseases is required.",
                    "sentences": [],
                    "annotations": [
                        {
                            "id": "4",
                            "infons": {
                                "identifier": "MESH:D006086",
                                "type": "Disease",
                                "valid": true,
                                "normalized": [
                                    "D006086"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D006086",
                                "biotype": "disease",
                                "name": "Graft vs Host Disease",
                                "accession": "@DISEASE_Graft_vs_Host_Disease"
                            },
                            "text": "graft-versus-host disease",
                            "locations": [
                                {
                                    "offset": 455,
                                    "length": 25
                                }
                            ]
                        },
                        {
                            "id": "5",
                            "infons": {
                                "identifier": "9606",
                                "type": "Species",
                                "valid": true,
                                "normalized": [
                                    9606
                                ],
                                "database": "ncbi_taxonomy",
                                "normalized_id": 9606,
                                "biotype": "species",
                                "name": "9606",
                                "accession": null
                            },
                            "text": "patients",
                            "locations": [
                                {
                                    "offset": 787,
                                    "length": 8
                                }
                            ]
                        }
                    ],
                    "relations": []
                }
            ],
            "relations": [],
            "pmid": 32202242,
            "pmcid": null,
            "meta": {},
            "date": "2020-06-01T00:00:00Z",
            "journal": "Hematol Oncol Stem Cell Ther",
            "authors": [
                "Oostenbrink LVE",
                "Jol-van der Zijde CM",
                "Jansen-Hoogendijk AM",
                "Pool ES",
                "van Halteren AGS",
                "Moes DJAR",
                "Bredius RGM",
                "Mohseny AB",
                "Smiers FJW",
                "van Tol MJD",
                "Schilham MW",
                "Lankester AC"
            ],
            "relations_display": []
        }
    ]
}